Status:

COMPLETED

Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM)

Lead Sponsor:

University of North Carolina, Chapel Hill

Conditions:

Acquired Immunodeficiency Syndrome

Eligibility:

MALE

16-24 years

Phase:

NA

Brief Summary

This study involves conducting formative research to develop a culturally appropriate secondary prevention intervention for HIV-positive Black young men who have sex with men (B-YMSM). The interventio...

Detailed Description

Focus groups will be conducted at two Adolescent Medicine Trials Unit (AMTU) sites and will guide the selection of the intervention content areas and the development of the intervention manual. The in...

Eligibility Criteria

Inclusion

  • Receives services at one of the selected AMTU sites;
  • Male sex at birth and male gender at the time of the study;
  • Self identifies as "Black" (including Black/African-American, Black Latino, Black/Afro-Caribbean, Black/African immigrant, or any self-identified member of the African Diaspora);
  • HIV-infected as documented by medical record review or verification with referring medical professional;
  • Between the ages of 16-24 years inclusive at the time of consent;
  • HIV-infected through sexual behavior;
  • At least one sexual encounter involving oral or anal sex with a male partner in the past year;
  • Ability to understand both written and spoken English;
  • Willingness to participate in a focus group discussion with other HIV-positive B-YMSM; and
  • Willingness to provide signed informed consent or assent with parental permission as applicable for study participation.

Exclusion

  • Active psychiatric condition that in the opinion of the site personnel would interfere with the ability to give true informed consent and to adhere to the study requirements;
  • Visibly distraught and/or visibly emotionally unstable (i.e., exhibiting suicidal, homicidal, or violent behavior);
  • Active drug or alcohol use or dependence that, in the opinion of the site personnel, would interfere with the ability to give true informed consent and to adhere to the study requirements;
  • Acute illness that, in the opinion of the treating clinician, would interfere with the participant's ability to adhere to the protocol requirements and/or interfere with the protocol objectives.

Key Trial Info

Start Date :

August 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2011

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT01502618

Start Date

August 1 2010

End Date

January 1 2011

Last Update

February 28 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.